• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC EXPORT UNKNOWN; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC EXPORT UNKNOWN; CATHETER, EMBOLECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 09/14/2021
Event Type  Injury  
Event Description
A journal article was submitted for review titled: in vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.The aim of the study was to investigate the incidence of newly formed healed plaque and different baseline characteristics of acute coronary syndrome (acs) patients caused by plaque erosion with or without newly formed healed plaque using optical coherence tomography (oct).Lesions treated included the left anterior descending artery (lad), left circumflex artery (lcx) and the right coronary artery (rca).Some lesions had multi-vessel disease and manual thrombectomies were required in some cases.Manual aspiration thrombectomy procedures were performed using an export catheter.A total of 137 acs patients with culprit plaque erosion who underwent pre-intervention oct imaging and received no stent implantation were enrolled.137 patients were reexamined with angiography and oct at 1-month follow-up and 52 patients were reexamined angiography and oct at 1-year follow-up.Patients were divided into different groups according to the presence or absence of newly formed healed plaque.During the 1 month oct follow-up 76 patients were in the group "patients with newly formed healed plaque" and 61 patients were in the group "patients without newly formed healed plaque".In the 1 year follow-up 36 patients were in the group "patients with newly formed healed plaque" and 16 patients were in the group "patients without newly formed healed plaque".Red and white thrombus were reported in both groups of patients at 1 month oct follow-up.There was incidents of ischemia-driven rev ascularization and stenosis reported in this study.Among 137 patients completed 1-month oct follow-up, 79 (57.7%) patients had healed plaque at baseline; 76 (55.5%) patients developed typical healed plaque; and 44 (32.1%) patients had healed plaque at baseline and newly formed healed plaque.In 52 patients completed 1-year oct follow-up, 22 (42.3%) patients had healed plaque at baseline; 36 (69.2%) patients developed typical healed plaque; 17 (32.7%) patients had healed plaque at baseline and newly formed healed plaque.Compared with patients without newly formed healed plaque, patients with newly formed healed plaque had smaller lipid arc, lower degree of percentage of area stenosis (as%), longer thrombus length, greater thrombus area, thrombus volume and thrombus burden.
 
Manufacturer Narrative
Journal article: in vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging authors:yanwei yin, chao fang, senqing jiang, jifei wang, yidan wang, junchen guo, fangmeng lei, sibo sun, xueying pei, ruyi jia, lulu li, yini wang, huai yu, jiannan dai, bo yu journal: american heart journal year: 2022 reference: doi: 10.1016/j.Ahj.2021.09.007.Average age.Majority gender.Date of publication.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPORT UNKNOWN
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer (Section G)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14641126
MDR Text Key293654039
Report Number1220452-2022-00042
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K152335
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/25/2022
Initial Date FDA Received06/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient SexMale
-
-